| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA651: Naldemedine for treating opioid-induced constipation |
|
Medicine details |
|
| Medicine name | naldemedine (Rizmoic®) |
| Formulation | 200 microgram film-coated tablet |
| Reference number | 2438 |
| Indication | Treatment of opioid-induced constipation in adult patients who have previously been treated with a laxative |
| Company | Shionogi Ltd |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 10/07/2019 |
| NICE guidance | |